Notice Number: NOT-CA-19-006
Key Dates
Release Date: October 23, 2018
Issued by
National Cancer Institute (NCI)
Purpose
The National Cancer Institute (NCI) will hold a public pre-application webinar on Thursday, November 1st, 2018, 1:10 PM-2:10 PM (EDT) for the Funding Opportunity Announcement (FOA) PAR-18-947: Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed).
Pre-Application Webinar
A public pre-application webinar will be held on Thursday, November 1st, 2018 ? at 1:10 p.m.- 2:10 p.m. (EDT) to provide information about the FOA to prospective applicants. NCI staff will provide an overview of the FOA and the application review process and answer questions from prospective applicants.
The webinar is open to all prospective applicants. Participation in this webinar, although encouraged, is optional and is not required for the submission of an application in response to PAR-18-947.
To join the webinar, follow the Webex link:
https://cbiit.webex.com/cbiit/j.php?MTID=m12e68b9e1a1e3064757e647e072b29ee
Audio connection:
1-650-479-3207Call-in toll number (US/Canada)
Access code: 739 679 487
Inquiries
Please direct all inquiries to:
Lokesh Agrawal, Ph.D.
National Cancer Institute (NCI)
Telephone: (240) 276-5718)
Email: [email protected]
Abhi Rao, Ph.D.)
National Cancer Institute (NCI))
Telephone: (240) 276-5715)
Email: [email protected]